Skip to content
2000
Volume 27, Issue 15
  • ISSN: 1385-2728
  • E-ISSN: 1875-5348

Abstract

Tuberculosis (TB) is the major cause of mortality around the world and one of the most common diseases linked to AIDS. Due to the emergence of multi-drug resistance, extensive drug resistance, and total drug resistance strains, TB has become a difficult disease to treat. Isoxazole scaffold shows a wide range of biological activities, including anticancer, antibacterial, anti-tubercular, antiviral, and anti-inflammatory activities etc. Several isoxazole derivatives have been produced and few of them have shown comparable anti-tubercular activity with standard drugs. In this review, we have focused on reported isoxazole derivatives having anti-tubercular activity and summarized their structure-activity relationship.

Loading

Article metrics loading...

/content/journals/coc/10.2174/0113852728264519231006055100
2023-08-01
2025-05-19
Loading full text...

Full text loading...

/content/journals/coc/10.2174/0113852728264519231006055100
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test